{"raw_mentions": "A \"structural mimic\" of peptide YY is a peptide of the invention, which has substantially the same or an enhanced IC50 value when compared to peptide YY when measured as binding to receptor Y2 in the assay set forth in example 2 or binding to receptor Y5 in the assay set forth in example 3.\nA \"functional mimic\" of peptide YY is a peptide of the invention, which has substantially the same or an enhanced EC 50 value when compared to peptide YY when measured in the efficacy assay set forth in example 2."}
{"final_json": [{"molecule_name": "peptide YY", "protein_target_name": "receptor Y2", "binding_metric": "IC50", "value": null, "unit": null}, {"molecule_name": "peptide YY", "protein_target_name": "receptor Y5", "binding_metric": "IC50", "value": null, "unit": null}, {"molecule_name": "peptide YY", "protein_target_name": null, "binding_metric": "EC 50", "value": null, "unit": null}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* Preferred peptides of the invention in any or both of these two assays exhibit an IC50 value which is at least 40% of that of peptide YY, such as at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 100%, at least 110%, at least 120%, at least 130%, at least 140%, and at least 150% of the IC50 value of the peptide having the amino acid sequence set forth in SEQ ID NO: 2.\n* Functional mimicry of the peptides of the invention is, according to the present invention, preliminarily gauged in the efficacy assay described in example 2. Preferred peptides of the invention in these two assays exhibit an EC50 value which is at least 40%o of that of peptide YY, such as at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 100%, at least 110%, at least 120%, at least 130%, at least 140%, and at least 150% of the EC50 value of the peptide having the amino acid sequence set forth in SEQ ID NO: 2.\n* In one embodiment the preferred peptides of the invention exhibit an EC50 < 1 nM in the efficacy assay set forth in Example 2 and/or exhibits an IC50 < 1 nM in the Y2 -binding assay set forth in Example 2 and/or exhibits an IC50 < 1 nm in the Y5-binding assay set forth in Example 3."}
{"final_json": [{"molecule_name": "peptide YY", "protein_target_name": null, "binding_metric": "IC50", "value": "40%", "unit": null}, {"molecule_name": "peptide YY", "protein_target_name": null, "binding_metric": "IC50", "value": "50%", "unit": null}, {"molecule_name": "peptide YY", "protein_target_name": null, "binding_metric": "IC50", "value": "60%", "unit": null}, {"molecule_name": "peptide YY", "protein_target_name": null, "binding_metric": "IC50", "value": "70%", "unit": null}, {"molecule_name": "peptide YY", "protein_target_name": null, "binding_metric": "IC50", "value": "80%", "unit": null}, {"molecule_name": "peptide YY", "protein_target_name": null, "binding_metric": "IC50", "value": "90%", "unit": null}, {"molecule_name": "peptide YY", "protein_target_name": null, "binding_metric": "IC50", "value": "100%", "unit": null}, {"molecule_name": "peptide YY", "protein_target_name": null, "binding_metric": "IC50", "value": "110%", "unit": null}, {"molecule_name": "peptide YY", "protein_target_name": null, "binding_metric": "IC50", "value": "120%", "unit": null}, {"molecule_name": "peptide YY", "protein_target_name": null, "binding_metric": "IC50", "value": "130%", "unit": null}, {"molecule_name": "peptide YY", "protein_target_name": null, "binding_metric": "IC50", "value": "140%", "unit": null}, {"molecule_name": "peptide YY", "protein_target_name": null, "binding_metric": "IC50", "value": "150%", "unit": null}, {"molecule_name": "peptide YY", "protein_target_name": null, "binding_metric": "EC50", "value": "40%", "unit": null}, {"molecule_name": "peptide YY", "protein_target_name": null, "binding_metric": "EC50", "value": "50%", "unit": null}, {"molecule_name": "peptide YY", "protein_target_name": null, "binding_metric": "EC50", "value": "60%", "unit": null}, {"molecule_name": "peptide YY", "protein_target_name": null, "binding_metric": "EC50", "value": "70%", "unit": null}, {"molecule_name": "peptide YY", "protein_target_name": null, "binding_metric": "EC50", "value": "80%", "unit": null}, {"molecule_name": "peptide YY", "protein_target_name": null, "binding_metric": "EC50", "value": "90%", "unit": null}, {"molecule_name": "peptide YY", "protein_target_name": null, "binding_metric": "EC50", "value": "100%", "unit": null}, {"molecule_name": "peptide YY", "protein_target_name": null, "binding_metric": "EC50", "value": "110%", "unit": null}, {"molecule_name": "peptide YY", "protein_target_name": null, "binding_metric": "EC50", "value": "120%", "unit": null}, {"molecule_name": "peptide YY", "protein_target_name": null, "binding_metric": "EC50", "value": "130%", "unit": null}, {"molecule_name": "peptide YY", "protein_target_name": null, "binding_metric": "EC50", "value": "140%", "unit": null}, {"molecule_name": "peptide YY", "protein_target_name": null, "binding_metric": "EC50", "value": "150%", "unit": null}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "EC50", "value": "< 1", "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "IC50", "value": "< 1", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "Y2", "binding_metric": "IC50", "value": "< 1", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "Y5", "binding_metric": "IC50", "value": "< 1", "unit": "nm"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nCell membranes (5-10 \u03bcg<sub>pro</sub>t) derived from SK-N-MC, SK-N-BE(2), SMS-KAN or brain cortex from adult rats are incubated with 0.2 nM [<sup>125</sup>I] {Leu3 l,Pro34}PYY (Yi - ligand) or 0.2 nM [ I]PYY<sub>3</sub>.<sub>36</sub> (Y<sub>2</sub> - ligand) in the absence or presence of increasing concentrations of test peptides in 200 \u03bcl binding buffer (50 mM HEPES, 2.5 mM CaCl<sub>2</sub>, 1 mM MgCl<sub>2</sub>, & 0.1% BSA, pH 7.2). \nNon specific binding are estimated at 1 \u03bcM {Leu31,Pro34}PYY (Yi) respectively PYY3-36 (Y2).\nThe compound is dissolved to reach a final concentration of 50 \u03bcg/ml.\nGroup 2: Low-fat, PYY analogueue 100 \u03bcg/kg\nGroup 4: High-fat, PYY analogueue 100 \u03bcg/kg"}
{"final_json": [{"molecule_name": "{Leu3 l,Pro34}PYY", "protein_target_name": null, "binding_metric": null, "value": "0.2", "unit": "nM"}, {"molecule_name": "[ I]PYY<sub>3</sub>.<sub>36</sub>", "protein_target_name": null, "binding_metric": null, "value": "0.2", "unit": "nM"}, {"molecule_name": "{Leu31,Pro34}PYY", "protein_target_name": null, "binding_metric": null, "value": "1", "unit": "\u03bcM"}, {"molecule_name": "PYY3-36", "protein_target_name": null, "binding_metric": null, "value": "1", "unit": "\u03bcM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": null, "value": "50", "unit": "\u03bcg/ml"}, {"molecule_name": "PYY analogueue", "protein_target_name": null, "binding_metric": null, "value": "100", "unit": "\u03bcg/kg"}, {"molecule_name": "PYY analogueue", "protein_target_name": null, "binding_metric": null, "value": "100", "unit": "\u03bcg/kg"}]}
